SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ORMP

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)

US · Delayed Price · Currency is USD
Also listed: ORMP.TAHealthcare · Biotechnology
4.08-0.05 (-1.21%)
 
Market cap
$170M
Analyst consensus
Listed since
May 1, 2007
Website
Insider Score
––Not scored
ORMP Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

ORMP Stock Insider Trading Activity

ORMP stock’s insider trading shows 4 sales on the open market for an estimated $1.17M by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Hexter Joshua
COO
Sell30,000$4.51$135.33K 2.2%1,328,130Oct 1, 2026— Form 4
Gabay Avraham
CFO
Sell20,000$4.51$90.20K 2.3%861,076Oct 1, 2026— Form 4
Kidron Miriam
Director
Award209,291—— 15.6%1,550,554Sep 24, 2026— Form 4
Kidron Miriam
Director
Award208,125—— 18.4%1,341,263Sep 24, 2026— Form 4
Hexter Joshua
COO
Award75,455—— 7.0%1,148,839Sep 24, 2026— Form 4
KIDRON NADAV
CEO
Award368,765—— 9.8%4,140,505Sep 24, 2026— Form 4
KIDRON NADAV
CEO
Award349,497—— 10.2%3,771,740Sep 24, 2026— Form 4
Hexter Joshua
COO
Award209,291—— 18.2%1,358,130Sep 24, 2026— Form 4
Gabay Avraham
CFO
Award209,291—— 31.2%881,076Sep 24, 2026— Form 4
Hexter Joshua
COO
Option exercise50,000$3.69$184.50K 4.9%1,073,384Jul 2, 2026— Form 4
Hexter Joshua
COO
Sell137,000$4.46$611.43K 11.8%1,023,384Jul 1, 2026— Form 4
Gabay Avraham
CFO
Sell73,360$4.51$330.74K 9.8%671,785Jul 1, 2026— Form 4
Kidron Miriam
Director
Tax withheld435,084$3.31$1.44M 27.7%1,133,138Mar 30, 2026— Form 4
KIDRON NADAV
CEO
Tax withheld44,818$3.31$148.35K 1.3%3,422,243Mar 30, 2026— Form 4
KIDRON NADAV
CEO
Award167,005—— 5.1%3,422,243Mar 17, 2026— Form 4
Hexter Joshua
COO
Award95,889—— 9.0%1,160,384Mar 17, 2026— Form 4
Gabay Avraham
CFO
Award95,889—— 14.8%745,145Mar 17, 2026— Form 4
Kidron Miriam
Director
Award119,558—— 8.3%1,568,222Mar 17, 2026— Form 4
KIDRON NADAV
CEO
Gift100,000—— 3.0%3,255,238Mar 12, 2026— Form 4
Hexter Joshua
COO
Option exercise19,000—— 1.8%1,064,495Jan 22, 2026— Form 4
KIDRON NADAV
CEO
Option exercise109,000—— 3.4%3,355,238Jan 22, 2026— Form 4
Gabay Avraham
CFO
Option exercise19,000—— 3.0%649,256Jan 22, 2026— Form 4
Kidron Miriam
Director
Option exercise19,000—— 1.3%1,448,664Jan 22, 2026— Form 4
Kidron Miriam
Director
Gift86,166—— 6.0%1,343,498Jan 14, 2026— Form 4
Gabay Avraham
CFO
Award81,216—— 18.7%515,256Dec 31, 2025— Form 4
Kidron Miriam
Director
Award115,000—— 8.7%1,429,664Dec 31, 2025— Form 4
Kidron Miriam
Director
Award121,331—— 10.2%1,314,664Dec 31, 2025— Form 4
Mayer Arie
Director
Award4,900—— 3.0%168,009Dec 31, 2025— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Sell (S) — Open-market or private sale
  • Award (A) — Grant or award from the company, not a purchase
  • Tax withheld (F) — Shares withheld to pay tax or an exercise price
  • Option exercise (M) — Exercise or conversion of an exempt derivative
  • Gift (G) — Bona fide gift
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.